Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Prédire la rechute d’épisodes dépressifs pendant le traitement d’entretien : Une étude de suivi du bien-être dans les troubles dépressifs majeurs du Réseau canadien d’intégration des biomarqueurs pour la dépression (CAN-BIND)
The Canadian Journal of Psychiatry · 2025
DOI: 10.1177/07067437251337603 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Canadian Journal of Psychiatry, 2025. Verfasst von Raymond W Lam und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of British Columbia, Vancouver, Canada. Hauptthemen laut MEDLINE: Major Depressive Disorder, Antidepressive Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ontario Brain Institute, Janssen Pharmaceutica.
Themen: Depression
Abstract (Originalsprache)
Background
Relapse rates in major depressive disorder (MDD) remain high even after treatment to remission. Identifying predictors of relapse is, therefore, crucial for improving maintenance strategies and preventing future episodes. Remote data collection and sensing technologies may allow for more comprehensive and longitudinal assessment of potential predictors.
Methods
The Canadian Biomarker Integration Network in Depression Wellness Monitoring for MDD (CBN-WELL) study was a prospective, multicentre observational study with an aim to identify biomarkers associated with relapse in patients on maintenance treatment for MDD. Participants had a DSM-5-TR diagnosis of MDD in remission and a Montgomery–Åsberg Depression Rating Scale (MADRS) score ≤14. Participants remained on their baseline medication regimens and were followed bimonthly for up to 2 years. Relapse criteria included MADRS > 22 for 2 consecutive weeks, suicidality or hospitalization, and initiation or change in medication for worsening symptoms. Data collection included clinical assessments, self-report questionnaires, and remote monitoring using wrist-worn actigraphs and smartphones.
Results
A total of 96 participants had follow-up data. Of these, 28.9% experienced a depressive relapse during the study period, with an average time to relapse of 211 days. Baseline depressive severity, as measured by MADRS, was higher in participants who relapsed compared to those who did not, but few other baseline clinical measures differentiated these groups.
Conclusions
Individuals with MDD in remission continued to have high relapse rates despite maintenance treatment. The paucity of clinical factors that predict relapse underscores the need for biomarkers. The CBN-WELL database can be used for future research to integrate multiple predictive factors and to identify objective measures to predict relapse in individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, University of British Columbia, Vancouver, Canada.
- Department of Psychology, University of British Columbia, Vancouver, Canada.
- Department of Psychiatry, University of Toronto, Toronto, Canada.
- Department of Psychiatry, Dalhousie University, Halifax, Canada.
- Department of Psychiatry, Center for Depression Research and Clinical Care, UT Southwestern Medical Center, Dallas, TX, USA.
- Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Canada.
ORCID-Profile: Raymond W Lam, Katerina Rnic, John-Jose Nunez, Joelle LeMoult, Benicio N Frey, Kate L Harkness, Sidney H Kennedy, Qingqin S Li, Roumen V Milev, Lena C Quilty, Susan Rotzinger, Valerie H Taylor, Rudolf Uher
Förderung
- Ontario Brain Institute
- Janssen Pharmaceutica
Zitieren
APA
Lam, R. W., Rnic, K., Nunez, J. J., Ho, K., LeMoult, J., Nunes, A., Chakrabarty, T., Foster, J. A., Frey, B. N., Harkness, K. L., Hassel, S., Kennedy, S. H., Li, Q. S., Milev, R. V., Quilty, L. C., Rotzinger, S., Soares, C. N., Taylor, V. H., Turecki, G., & Uher, R. (2025). Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Prédire la rechute d’épisodes dépressifs pendant le traitement d’entretien : Une étude de suivi du bien-être dans les troubles dépressifs majeurs du Réseau canadien d’intégration des biomarqueurs pour la dépression (CAN-BIND). The Canadian Journal of Psychiatry. https://doi.org/10.1177/07067437251337603
Vancouver
Lam RW, Rnic K, Nunez JJ, Ho K, LeMoult J, Nunes A, et al. Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Prédire la rechute d’épisodes dépressifs pendant le traitement d’entretien : Une étude de suivi du bien-être dans les troubles dépressifs majeurs du Réseau canadien d’intégration des biomarqueurs pour la dépression (CAN-BIND). The Canadian Journal of Psychiatry. 2025. doi:10.1177/07067437251337603
BibTeX
@article{Lam2025,
author = {Lam, Raymond W and Rnic, Katerina and Nunez, John-Jose and Ho, Keith and LeMoult, Joelle and Nunes, Abraham and Chakrabarty, Trisha and Foster, Jane A and Frey, Benicio N and Harkness, Kate L and Hassel, Stefanie and Kennedy, Sidney H and Li, Qingqin S and Milev, Roumen V and Quilty, Lena C and Rotzinger, Susan and Soares, Claudio N and Taylor, Valerie H and Turecki, Gustavo and Uher, Rudolf},
title = {Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Prédire la rechute d’épisodes dépressifs pendant le traitement d’entretien : Une étude de suivi du bien-être dans les troubles dépressifs majeurs du Réseau canadien d’intégration des biomarqueurs pour la dépression (CAN-BIND)},
journal = {The Canadian Journal of Psychiatry},
year = {2025},
doi = {10.1177/07067437251337603}
}
EUVIMED